ANI Pharmaceuticals to Announce Financial Results
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is preparing to share its financial results for the third quarter of 2024 on November 8. The Company will issue this report before the stock market opens, marking an important occasion for investors and stakeholders.
Conference Call Details
Following the release of the financial results, a conference call will be hosted to provide further insights into the outcomes. Key participants in this call will include Nikhil Lalwani, President and CEO; Stephen P. Carey, Senior VP of Finance and CFO; and Chris Mutz, who oversees the Rare Disease sector. This session will be a chance for attendees to gain a deeper understanding of the Company’s performance and future direction.
Call Schedule
The conference call is slated for 8:00 a.m. ET on November 8. Participants can access the call in several ways:
- Toll-Free Number (U.S.): 800-445-7795
- Conference ID: 4757982
For those unable to join the live discussion, a replay will be available shortly after the call, lasting two weeks. The replay can be accessed by dialing 800-839-8389 and entering the same access code.
Profile of ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals is a rapidly growing biopharmaceutical company that emphasizes the importance of serving patients and improving their quality of life. The Company specializes in the development and commercialization of innovative therapeutics, reflecting its commitment to high standards in the pharmaceutical industry.
Business Areas
The Company operates through several segments, focusing on Rare Diseases, Generics, and Established Brands. The Rare Disease division is particularly significant as it addresses specialized medical conditions through groundbreaking therapies. Meanwhile, the Generics segment relies on robust research and development, operational expertise, and efficient U.S.-based manufacturing practices.
Accessing Company Information
For additional information regarding ANI Pharmaceuticals, investors and interested parties are encouraged to visit the Company’s official website. All updates, including press releases and the latest news about the Company’s initiatives, are regularly published there. The link is www.anipharmaceuticals.com.
Contacting Investor Relations
For inquiries, Lisa M. Wilson from In-Site Communications, Inc. can be reached at 212-452-2793. She is responsible for managing investor relations and will be happy to assist with any questions regarding the upcoming financial report or other Company matters.
Frequently Asked Questions
When will ANI Pharmaceuticals release its third quarter results?
The results will be released on November 8, before market opening.
How can I participate in the conference call?
Dial 800-445-7795 and enter the Conference ID 4757982 to join the call.
Will a replay of the call be available?
Yes, the call replay will be accessible within two hours of the call's completion and will last for two weeks.
What does ANI Pharmaceuticals specialize in?
ANI focuses on developing innovative therapies for Rare Diseases along with Generics and Established Brands.
Who can I contact for investor inquiries?
Lisa M. Wilson at In-Site Communications, Inc. can be contacted at 212-452-2793 for any investor-related questions.
